{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:04:23Z","timestamp":1792242263457,"version":"4.4.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136910","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T18:36:12Z","timestamp":1440786972000},"page":"e0136910","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials"],"prefix":"10.1371","volume":"10","author":[{"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2869.2002.00317.x","article-title":"Insomnia and global sleep dissatisfaction in Finland","volume":"11","author":"MM Ohayon","year":"2002","journal-title":"Journal of sleep research"},{"issue":"1\u20133","key":"ref2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00072-1","article-title":"Primary insomnia: a risk factor to develop depression?","volume":"76","author":"D Riemann","year":"2003","journal-title":"Journal of affective disorders"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.sleep.2013.11.788","article-title":"Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis","volume":"15","author":"A Kuriyama","year":"2014","journal-title":"Sleep medicine"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40263-014-0198-7","article-title":"Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials","volume":"28","author":"A Winkler","year":"2014","journal-title":"CNS drugs"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"M Lader","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.08m04325","article-title":"Benzodiazepine use and driving: a meta-analysis","volume":"70","author":"MJ Rapoport","year":"2009","journal-title":"The Journal of clinical psychiatry"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.13011su1c","article-title":"Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system","volume":"74","author":"AD Krystal","year":"2013","journal-title":"The Journal of clinical psychiatry"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0976-500X.155496","article-title":"Suvorexant: The first orexin receptor antagonist to treat insomnia","volume":"6","author":"AK Dubey","year":"2015","journal-title":"Journal of pharmacology & pharmacotherapeutics"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"WJ Herring","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"D Michelson","year":"2014","journal-title":"The Lancet Neurology"},{"key":"ref11","article-title":"Suvorexant in Patients with Insomnia: Results from Two 3-Month Randomized Controlled Clinical Trials","author":"WJ Herring","year":"2014","journal-title":"Biological psychiatry"},{"key":"ref12","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration. 2011;<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cochrane-handbook.org\" xlink:type=\"simple\">www.cochrane-handbook.org<\/ext-link>."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"Bmj"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"CH Bastien","year":"2001","journal-title":"Sleep medicine"},{"key":"ref15","article-title":"Manual for the ECDEU Assessment Battery","author":"W Guy","year":"1970"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-0327(90)90009-W","article-title":"The Benzodiazepine Withdrawal Symptom Questionnaire","volume":"19","author":"P Tyrer","year":"1990","journal-title":"Journal of affective disorders"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref18","unstructured":"Merck. 2014; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.merck.com\/product\/usa\/pi_circulars\/b\/belsomra\/belsomra_pi.pdf\" xlink:type=\"simple\">http:\/\/www.merck.com\/product\/usa\/pi_circulars\/b\/belsomra\/belsomra_pi.pdf<\/ext-link>."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnins.2014.00008","article-title":"Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep\/wakefulness states in mice","volume":"8","author":"K Etori","year":"2014","journal-title":"Frontiers in neuroscience"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnins.2014.00057","article-title":"OX1 and OX2 orexin\/hypocretin receptor pharmacogenetics","volume":"8","author":"MD Thompson","year":"2014","journal-title":"Frontiers in neuroscience"},{"key":"ref21","first-page":"36","article-title":"Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls","volume":"8","author":"JW Yeoh","year":"2014","journal-title":"Frontiers in neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnins.2014.00005","article-title":"LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy","volume":"8","author":"TE Fitch","year":"2014","journal-title":"Frontiers in neuroscience"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jsmc.2013.04.007","article-title":"Insomnia comorbid to severe psychiatric illness","volume":"8","author":"AM Soehner","year":"2013","journal-title":"Sleep medicine clinics"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/ijcp.12568","article-title":"Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic\u2014what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?","volume":"68","author":"L Citrome","year":"2014","journal-title":"Int J Clin Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:55:50Z","timestamp":1588992950000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136910"}},"subtitle":[],"editor":[{"given":"Gianni","family":"Virgili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136910","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}